Compounds and methods for the treatment of non-alcoholic steatohepatitis /
Title
Compounds and methods for the treatment of non-alcoholic steatohepatitis /
Subject
Medicinal Chemistry
Description
Patent Number: WO2019111225, Applicant: AVALIV THERAPEUTICS.
Compounds and compositions are provided having the structure of Formula (I) or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein T, T', U, U', V, W, R1, R2, R3', n, o, o', o'', and o''' are as defined herein. Suchcompounds are useful for treating liver diseases and abnormal liver conditions, including non-alcoholic steatohepatitis via inhibition of the lysosomal enzyme cathepsin D.
Compounds and compositions are provided having the structure of Formula (I) or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein T, T', U, U', V, W, R1, R2, R3', n, o, o', o'', and o''' are as defined herein. Suchcompounds are useful for treating liver diseases and abnormal liver conditions, including non-alcoholic steatohepatitis via inhibition of the lysosomal enzyme cathepsin D.
Creator
Agarwal, Anil Kumar.
Publisher
World Intellectual Property Organization
Date
2019
Language
English
Type
Patent
Collection
Citation
Agarwal, Anil Kumar., “Compounds and methods for the treatment of non-alcoholic steatohepatitis /,” CHRIST (Deemed To Be University) Institutional Repository, accessed November 21, 2024, https://archives.christuniversity.in/items/show/2317.